Guidance and quality standards Awaiting development
Showing 1 to 7 of 7
Title | Type |
---|---|
Dupilumab for treating eosinophilic oesophagitis in children 1 to 11 years TS ID 11885 | Technology appraisal guidance |
Evinacumab for treating homozygous familial hypercholesterolemia in children aged 5 to 11 TS ID 11806 | Technology appraisal guidance |
Odevixibat for treating biliary atresia in children following Kasai hepatoportoenterostomy TSID 11996 | Technology appraisal guidance |
Perampanel for adjunctive treatment of partial onset or generalised tonic-clonic seizures in children aged below 12 years with epilepsy ID1587 | Technology appraisal guidance |
Setmelanotide for treating obesity caused by a rare genetic disorder in children aged 2 to 5 TS ID 11827 | Technology appraisal guidance |
Vosoritide for treating achondroplasia in children TSID 12001 | Technology appraisal guidance |
Vosoritide for treating achondroplasia in children and young people under 18 years [ID3807] | Technology appraisal guidance |